134 related articles for article (PubMed ID: 20206532)
1. Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening.
Okamoto M; Takayama K; Shimizu T; Muroya A; Furuya T
Bioorg Med Chem; 2010 Apr; 18(7):2728-34. PubMed ID: 20206532
[TBL] [Abstract][Full Text] [Related]
2. Identification of death-associated protein kinases inhibitors using structure-based virtual screening.
Okamoto M; Takayama K; Shimizu T; Ishida K; Takahashi O; Furuya T
J Med Chem; 2009 Nov; 52(22):7323-7. PubMed ID: 19877644
[TBL] [Abstract][Full Text] [Related]
3. Novel lead structures for p38 MAP kinase via FieldScreen virtual screening.
Cheeseright TJ; Holm M; Lehmann F; Luik S; Göttert M; Melville JL; Laufer S
J Med Chem; 2009 Jul; 52(14):4200-9. PubMed ID: 19489590
[TBL] [Abstract][Full Text] [Related]
4. Virtual screening to successfully identify novel janus kinase 3 inhibitors: a sequential focused screening approach.
Chen X; Wilson LJ; Malaviya R; Argentieri RL; Yang SM
J Med Chem; 2008 Nov; 51(21):7015-9. PubMed ID: 18844338
[TBL] [Abstract][Full Text] [Related]
5. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening.
Nagarajan S; Doddareddy Mr; Choo H; Cho YS; Oh KS; Lee BH; Pae AN
Bioorg Med Chem; 2009 Apr; 17(7):2759-66. PubMed ID: 19285872
[TBL] [Abstract][Full Text] [Related]
6. Structure of the dimeric autoinhibited conformation of DAPK2, a pro-apoptotic protein kinase.
Patel AK; Yadav RP; Majava V; Kursula I; Kursula P
J Mol Biol; 2011 Jun; 409(3):369-83. PubMed ID: 21497605
[TBL] [Abstract][Full Text] [Related]
7. Death-associated protein kinase as a potential therapeutic target.
Schumacher AM; Velentza AV; Watterson DM
Expert Opin Ther Targets; 2002 Aug; 6(4):497-506. PubMed ID: 12223064
[TBL] [Abstract][Full Text] [Related]
8. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.
Rella M; Rushworth CA; Guy JL; Turner AJ; Langer T; Jackson RM
J Chem Inf Model; 2006; 46(2):708-16. PubMed ID: 16563001
[TBL] [Abstract][Full Text] [Related]
9. Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4).
Lafleur K; Huang D; Zhou T; Caflisch A; Nevado C
J Med Chem; 2009 Oct; 52(20):6433-46. PubMed ID: 19788238
[TBL] [Abstract][Full Text] [Related]
10. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
Chuaqui C; Deng Z; Singh J
J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-beta type I receptor (ALK5) inhibitors.
Ren JX; Li LL; Zou J; Yang L; Yang JL; Yang SY
Eur J Med Chem; 2009 Nov; 44(11):4259-65. PubMed ID: 19640613
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel purine derivatives with potent and selective inhibitory activity against c-Src tyrosine kinase.
Huang H; Ma J; Shi J; Meng L; Jiang H; Ding J; Liu H
Bioorg Med Chem; 2010 Jul; 18(13):4615-24. PubMed ID: 20570525
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the kinase domain in death-associated protein kinase attenuates renal tubular cell apoptosis in chronic obstructive uropathy.
Yukawa K; Hoshino K; Kishino M; Mune M; Shirasawa N; Kimura A; Tsubota Y; Owada-Makabe K; Tanaka T; Ichinose M; Maeda M; Takeda K; Akira S
Int J Mol Med; 2004 Apr; 13(4):515-20. PubMed ID: 15010850
[TBL] [Abstract][Full Text] [Related]
14. Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitors.
Cole DC; Asselin M; Brennan A; Czerwinski R; Ellingboe JW; Fitz L; Greco R; Huang X; Joseph-McCarthy D; Kelly MF; Kirisits M; Lee J; Li Y; Morgan P; Stock JR; Tsao DH; Wissner A; Yang X; Chaudhary D
J Med Chem; 2008 Oct; 51(19):5958-63. PubMed ID: 18783200
[TBL] [Abstract][Full Text] [Related]
15. Death-associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death.
Lin Y; Hupp TR; Stevens C
FEBS J; 2010 Jan; 277(1):48-57. PubMed ID: 19878313
[TBL] [Abstract][Full Text] [Related]
16. Identification and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase.
Sliman F; Blairvacq M; Durieu E; Meijer L; Rodrigo J; Desmaële D
Bioorg Med Chem Lett; 2010 May; 20(9):2801-5. PubMed ID: 20363627
[TBL] [Abstract][Full Text] [Related]
17. Cell division cycle 7 kinase inhibitors: 1H-pyrrolo[2,3-b]pyridines, synthesis and structure-activity relationships.
Ermoli A; Bargiotti A; Brasca MG; Ciavolella A; Colombo N; Fachin G; Isacchi A; Menichincheri M; Molinari A; Montagnoli A; Pillan A; Rainoldi S; Sirtori FR; Sola F; Thieffine S; Tibolla M; Valsasina B; Volpi D; Santocanale C; Vanotti E
J Med Chem; 2009 Jul; 52(14):4380-90. PubMed ID: 19555113
[TBL] [Abstract][Full Text] [Related]
18. Discovery of the inhibitors of tumor necrosis factor alpha with structure-based virtual screening.
Choi H; Lee Y; Park H; Oh DS
Bioorg Med Chem Lett; 2010 Nov; 20(21):6195-8. PubMed ID: 20850306
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics, density functional, ADMET predictions, virtual screening, and molecular interaction field studies for identification and evaluation of novel potential CDK2 inhibitors in cancer therapy.
da Silva VB; Kawano DF; Gomes Ada S; Carvalho I; Taft CA; da Silva CH
J Phys Chem A; 2008 Sep; 112(38):8902-10. PubMed ID: 18698751
[TBL] [Abstract][Full Text] [Related]
20. A calmodulin-regulated protein kinase linked to neuron survival is a substrate for the calmodulin-regulated death-associated protein kinase.
Schumacher AM; Schavocky JP; Velentza AV; Mirzoeva S; Watterson DM
Biochemistry; 2004 Jun; 43(25):8116-24. PubMed ID: 15209507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
